Search

Search Results

• CO13 | Genetic background in hypercholesterolemic patients framing cardiovascular risk A. Kura¹, E. Sticchi², G. Barbieri¹, R. Orsi¹, S. Suraci¹, G.M. Scaturro³, E. Lotti⁴, F. Crudele⁴, M. Berteotti², A.M. Gori², R. Marcucci², B. Giusti² | ¹Department of Experimental and Clinical Medicine, Firenze; ²Department of Experimental and Clinical Medicine, Atherothrombotic Diseases Center, Careggi Hospital, Firenze; ³Meyer Children’s Hospital IRCCS, Firenze; ⁴Atherothrombotic Diseases Center, Careggi Hospital, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.217

  723

  PDF: 25

• CS08 | A combination of two rapid immunoassays improves HIT diagnosis G. Ciarrocca Taranta¹, A. Rogolino², A. Bertelli¹, A. Sorrentino¹, M. Di Gioia², F. Cesari², B. Giusti^1,2, E. Sticchi^1,2, M. Berteotti^1,2, A.M. Gori^1,2, R. Marcucci^1,2 | ¹Department of Experimental and Clinical Medicine, University of Firenze; ²Atherothrombotic Disease Unit, Careggi University Hospital, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.205

  709

  PDF: 15

• CO50 | Diagnostic accuracy of the heparin-induced multiple electrode aggregometry (HIMEA) functional test for heparin-induced thrombocytopenia M. Bovara¹, M. Sebastiani², Am. Gori^3,4, A. Rogolino^3,4, A. Bertelli^3,4, G. Ciarrocca Taranta^3,4, R. Marcucci^3,4, M. Sartori⁵, B. Cosmi⁵, M. Silingardi⁶, A. M. Pizzini⁶, A. Marrocchi¹, R. Mancini¹ | ¹Laboratorio Unico Metropolitano Ospedale Maggiore, AUSL Bologna; ²IRCCS Istituto delle Scienze Neurologiche, Bologna; ³Centro Malattie Aterotrombotiche Azienda Ospedaliera Universitaria Careggi, Firenze; ⁴Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze; ⁵U.O. di Angiologia e Malattie della Coagulazione dell’Azienda Ospedaliero Universitaria Policlinico S. Orsola-Malpighi, Bologna; ⁶Medicina Interna Ospedale Maggiore, Bologna, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.260

  623

  PDF: 17

• CO43 | Early platelet dysfunction in sepsis: an ICU pilot study S. Sorrentino¹, C. Gori², L. D’Innocenzo¹, M. De Siati¹, Mg. Bocci³, E. De Candia¹ | ¹Unit of Haemostasis and Thrombosis Diseases, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma; ²UOC Shock & Trauma, Azienda Ospedaliera San Camillo Forlanini, Roma; ³National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.249

  658

  PDF: 17

• CO26 | Relationship between SMAD3 variants and non-aortic cardiovascular features L. Squillantini, E. Sticchi, P. Cantini, S. Suraci, A. Rogolino, F. Gensini, S. Nistri, G. Pepe, A.M. Gori, M. Berteotti, R. Marcucci, B. Giusti | Università degli Studi di Firenze, Dipartimento di Medicina Sperimentale e Clinica, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.232

  590

  PDF: 18

• CO23 | Markers of inflammation and hypofibrinolysis are associated with cognitive dysfunction and motor performances in atrial fibrillation patients on oral anticoagulant therapy: insights from the Strat-AF study F. Alfano^1,2, F. Cesari^1,2, A.M. Gori^1,2, M. Berteotti^1,2, E. Salvadori³, B. Giusti^1,2, A. Bertelli^1,2, F. Fratini⁴, A. Rogolino^1,2, B. Formelli^4,5, F. Pescini^4,5, E. Fainardi⁶, E. Barucci⁴, G. Salti⁵, A. Cavaliere⁴, A. Ginestroni⁶, A. Poggesi^4,5, R. Marcucci^1,2 | ¹Department of Experimental and Clinical Medicine, University of Firenze; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze; ³Department of Biomedical and Clinical Sciences, University of Milan; ⁴NEUROFARBA Department, Neuroscience Section, University of Firenze; ⁵Stroke Unit, Careggi University Hospital, Firenze; ⁶Neuroradiology Unit, Careggi University Hospital, Department of Experimental and Clinical Biomedical Sciences, University of Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.229

  732

  PDF: 26

• CO024 | THE ROLE OF BLOOD CLOTTING AND ENDOTHELIAL ACTIVATION IN THE STRATIFICATION OF BLEEDING AND THROMBOTIC RISK OF ATRIAL FIBRILLATION ON ORAL ANTICOAGULANT THERAPY: INSIGHTS FROM THE STRAT-AF 2 STUDY F. Alfano^1|2, AM. Gori^1|2, A. Bertelli¹, G. Ciarrocca Taranta¹, M. Di Gioia², F. Cesari¹, A. Rogolino¹, A. Sorrentino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Francesco Alfano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.726

  35

  PDF: 11

• CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS J. Patrussi¹, A. Vignoli^1|2, L. Tenori^1|2, A. Sorrentino³, M. Berteotti^3|4, E. Lotti⁴, F. Crudele⁴, G. Ciarrocca Taranta³, A.A. Rogolino⁴, G. Barbieri³, A.M. Gori^3|4, R. Marcucci^3|4 | ¹Dep. of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy; ²Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; ³Dep. of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ⁴Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  Andrea Sorrentino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.780

  28

  PDF: 9

• CO021 | TIME COURSE OF LP(a) LEVELS AFTER ACUTE CORONARY SYNDROME: A LONGITUDINAL STUDY G. Barbieri¹, A.M. Gori¹, G. Ciarrocca Taranta¹, M. Di Gioia¹, F. Alfano¹, E. Lotti¹, A. Rogolino¹, F. Cesari¹, B. Giusti¹, M. Berteotti¹, R. Marcucci¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy

  Giulia Barbieri

  26-10-2026

  https://doi.org/10.4081/btvb.2026.723

  36

  PDF: 11

• CO073 | THROMBIN GENERATION PROFILE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF ORAL ANTICOAGULANT TYPE M. Di Gioia¹, M. Berteotti^1|2, G. Ciarrocca Taranta², F. Alfano^1|2, F. Crudele¹, F. Cesari¹, A.M. Gori^1|2, A. Rogolino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy; ²Dep. of Experimental and Clinical Medicine, University of Florence, Italy

  Michela Di Gioia

  26-10-2026

  https://doi.org/10.4081/btvb.2026.775

  26

  PDF: 9
• 

  In memoriam of  Professor Gian Franco Gensini (1945-2026)

  Betti Giusti, Anna Maria Gori, Rossella Marcucci, Domenico Prisco, Francesco Sofi

  08-05-2026

  https://doi.org/10.4081/btvb.2026.568

  970

  PDF: 360

• CO071 | ATRIAL FIBRILLATION, CEREBRAL SMALL VESSEL DISEASE, AND GENDER MEDICINE: FOCUS ON BIOMARKERS AND NEUROIMAGING F. Alfano^1|2, M. Berteotti^1|2, F. Cesari^1|2, AM. Gori^1|2, E. Salvadori¹, B. Giusti^1|2, A. Bertelli^1|2, L. Bicchi^1|2, F. Fratini³, B. Formelli³, G. Salti³, E. Fainardi^1|4, A. Ginestroni^1|4, S. Chiti⁵, A. Poggesi^1|3, R. Marcucci^1|2 | ¹Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy; ³NEUROFARBA Department, Neuroscience Section, University of Florence, Firenze, Italy; ⁴Neuroradiology Unit, Careggi University Hospital, Firenze, Italy; ⁵Health Physics Unit, Careggi University Hospital, Firenze, Italy

  Francesco Alfano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.773

  39

  PDF: 17
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  https://doi.org/10.4081/btvb.2022.50

  1897

  PDF: 647

• PO137 | SMAD3 VARIANTS IN LOEYS-DIETZ SYNDROME: RELATIONSHIP WITH NON-AORTIC CARDIOVASCULAR FEATURES E. Sticchi¹, L. Squillantini¹, P. Cantini¹, S. Suraci¹, F. Basso¹, G. Barbieri¹, A. Kura¹, F. Gensini², E. Fiorentini², S. Nistri³, G. Pepe¹, A.M. Gori¹, M. Berteotti¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Dpt. Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy; ²Dpt. Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Firenze, Italy; ³Cardiology Service CMSR Veneto Medica Altavilla Vicentina, Vicenza, Italy

  Elena Sticchi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.953

  26

  PDF: 10

• CO070 | PLASMIN GENERATION AND ITS INTERPLAY WITH COAGULATION AND FIBRINOLYSIS IN ATRIAL FIBRILLATION: IMPACT OF ANTICOAGULANT THERAPY G. Ciarrocca Taranta¹, F. Alfano¹, M. Di Gioia², M. Berteotti^1|2, E. Lotti², F. Cesari², A. Rogolino², F.A. Barbuto¹, A. M Gori^1|2, E. Sticchi^1|2, B. Giusti^1|2, R. Marcucci^1|2 | ¹Dep of Experimental and Clinical Medicine, University of Florence, Italy; ²Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.772

  31

  PDF: 7

• PO134 | FAMILIAL HYPERCHOLESTEROLEMIA 57-GENE PANEL MUTATIONAL ANALYSIS: INSIGHT INTO CARDIOVASCULAR RISK GENETIC PREDISPOSITION A. Kura¹, E. Sticchi¹, G. Barbieri¹, F. Basso¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Ada Kura

  26-10-2026

  https://doi.org/10.4081/btvb.2026.950

  28

  PDF: 7

• CO060 | LP(a) AND CARDIOVASCULAR RISK IN FAMILIAL HYPERCHOLESTEROLEMIA F. Basso¹, G. Barbieri¹, E. Sticchi¹, A. Kura¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Francesca Basso

  26-10-2026

  https://doi.org/10.4081/btvb.2026.762

  30

  PDF: 10

• PO050 | HEMOSTATIC AND FIBRINOLYTIC PROFILES IN PATIENTS UNDERGOING TAVI: PRELIMINARY RESULTS ON HOMOCYSTEINE, D-DIMER, AND CLOT LYSIS TIME V. Scheggi¹, A. Bertelli², F. Cesari³, A. Rogolino³, G. Ciarrocca Taranta², M. Di Gioia³, G. Barbieri², A.M. Gori^2|3, R. Marcucci^2|3 | ¹Dep of Cardiothoracovascular Medicine, Careggi University Hospital, Firenze, Italy; ²Dep of Experimental and Clinical Medicine, University of Florence, Italy; ³Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.866

  33

  PDF: 9

• CO045 | BEYOND THE VISIBLE: LIPOPROTEIN(a) AS A SILENT DRIVER OF RETINAL VASCULAR DAMAGE L. Agrelli¹, M. Berteotti², E. Lotti², F. Crudele², D. Poli², A.M. Gori², A Rogolino², D. Prisco², R. Marcucci² | ¹Department of Internal Medicine, University of Salerno, Italy; ²Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, AOU Careggi, Firenze, Italy

  Lucia Agrelli

  26-10-2026

  https://doi.org/10.4081/btvb.2026.747

  30

  PDF: 10

• CO099 | OPTIMIZING CUT-OFFS FOR LUPUS ANTICOAGULANT TESTING: EVIDENCE FROM A MULTICENTER REGIONAL STUDY S. Nannini¹, G. Andreani², C. Bellini³, M. Bombara⁴, S. Brizzi¹, P. Calzoni⁵, M. Casini⁶, F. Cesari⁷, D. Fineschi⁸, A.M.G. Gelli⁹, L. Iordache¹⁰, M. Lorubbio¹¹, M. Martelloni⁹, A. Rogolino⁷, V. Scaccia³, M. Spagnuolo⁴, A. Terrosi³, F. Veneziani¹², R. Marcucci⁷, A.M. Gori⁷ | ¹SOS Patologia Clinica San Jacopo, Pistoia e SS Cosma e Damiano, Pescia, Azienda USL Toscana Centro, Italy; ²S.S.D Analisi Chimico-Cliniche Apuane e Microbiologia molecolare, Osp. delle Apuane, Azienda U.S.L Toscana Nord-Ovest, Italy; ³Lab. Analisi Chimico-Cliniche, Dip. di Medicina Diagnostica, Trasfusionale e Dei Servizi, Osp. Misericordia Grosseto AUSL TSE, Italy; ⁴Azienda USL Toscana Nordovest - Dipartimento Diagnostiche di Laboratorio, U.O.C. Laboratorio Analisi Chimico Cliniche, Ambito Territoriale Livorno, Italy; ⁵UOS Coagulazione, UOC Laboratorio di Patologia Clinica, AOU Senese, Italy; ⁶U.O. Analisi Chimico-Cliniche Azienda Ospedaliero Universitaria Pisana, Italy; ⁷Azienda Ospedaliero Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Italy; ⁸UOC Laboratorio di Patologia Clinica, AOU Senese, Italy; ⁹SOS Patologia Clinica PO San Giuseppe, Empoli, Italy; ¹⁰Laboratorio Di Analisi Chimico-Cliniche E Microbiologiche, Ospedale Santo Stefano, Prato, Italy; ¹¹UOSD Medicina di Laboratorio Valdarno, Azienda USL Toscana Sud Est, Arezzo, Italy; ¹²Laboratorio Patologia Clinica, Ospedale San Giovanni di Dio, Firenze, Italy

  Michela Di Gioia

  26-10-2026

  https://doi.org/10.4081/btvb.2026.801

  26

  PDF: 10